416 related articles for article (PubMed ID: 35061218)
1. Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches.
Sheibani M; Azizi Y; Shayan M; Nezamoleslami S; Eslami F; Farjoo MH; Dehpour AR
Cardiovasc Toxicol; 2022 Apr; 22(4):292-310. PubMed ID: 35061218
[TBL] [Abstract][Full Text] [Related]
2. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
3. The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
Timm KN; Tyler DJ
Cardiovasc Drugs Ther; 2020 Apr; 34(2):255-269. PubMed ID: 32034646
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
5. Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis.
Saleh MF; Elsayad ME; Goda AE
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6573-6584. PubMed ID: 34787860
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study.
Maleki F; Rabbani S; Shirkoohi R; Rezaei M
Biomed Pharmacother; 2023 Dec; 168():115651. PubMed ID: 37812888
[TBL] [Abstract][Full Text] [Related]
7. Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death.
Kong CY; Guo Z; Song P; Zhang X; Yuan YP; Teng T; Yan L; Tang QZ
Int J Biol Sci; 2022; 18(2):760-770. PubMed ID: 35002523
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
9. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
Li W; Xu B; Xu J; Wu XL
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
[TBL] [Abstract][Full Text] [Related]
10. Complications of chemotherapy, a basic science update.
Mazevet M; Moulin M; Llach-Martinez A; Chargari C; Deutsch E; Gomez AM; Morel E
Presse Med; 2013 Sep; 42(9 Pt 2):e352-61. PubMed ID: 23972551
[TBL] [Abstract][Full Text] [Related]
11. Role of mitochondria in doxorubicin-mediated cardiotoxicity: From molecular mechanisms to therapeutic strategies.
Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
Cell Stress Chaperones; 2024 Apr; 29(2):349-357. PubMed ID: 38485043
[TBL] [Abstract][Full Text] [Related]
12. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
Ghigo A; Li M; Hirsch E
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
[TBL] [Abstract][Full Text] [Related]
13. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
14. The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.
Russo M; Guida F; Paparo L; Trinchese G; Aitoro R; Avagliano C; Fiordelisi A; Napolitano F; Mercurio V; Sala V; Li M; Sorriento D; Ciccarelli M; Ghigo A; Hirsch E; Bianco R; Iaccarino G; Abete P; Bonaduce D; Calignano A; Berni Canani R; Tocchetti CG
Eur J Heart Fail; 2019 Apr; 21(4):519-528. PubMed ID: 30843309
[TBL] [Abstract][Full Text] [Related]
15. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
16. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer.
Ghasemi K; Vaseghi G; Mansourian M
J Oncol Pharm Pract; 2021 Mar; 27(2):414-427. PubMed ID: 33081570
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin.
Govender J; Loos B; Marais E; Engelbrecht AM
J Pineal Res; 2014 Nov; 57(4):367-80. PubMed ID: 25230823
[TBL] [Abstract][Full Text] [Related]
19. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
[TBL] [Abstract][Full Text] [Related]
20. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice.
Sahu BD; Kumar JM; Kuncha M; Borkar RM; Srinivas R; Sistla R
Life Sci; 2016 Jan; 144():8-18. PubMed ID: 26606860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
